Travelers (NYSE: TRV) grants 14,691 stock options to vice chairman

Q: What insider transaction did TRV report for Avrohom J. Kess?

Travelers disclosed a stock option grant to Avrohom J. Kess. On February 3, 2026, he received options to buy 14,691 shares of common stock, reflecting routine executive compensation rather than an open-market purchase or sale.

Q: How many Travelers (TRV) stock options were granted to Avrohom J. Kess?

Avrohom J. Kess was granted 14,691 stock options . Each option represents the right to buy one share of Travelers common stock, giving him potential future ownership of up to 14,691 shares if exercised.

Q: What is the exercise price of the new TRV stock options granted?

The newly granted stock options have an exercise price of $288.23 per share . This means Kess can buy Travelers common stock at $288.23 if he exercises the options once they become exercisable.

Q: When do Avrohom J. Kess’s Travelers stock options vest and expire?

The options become exercisable on February 3, 2029 and expire on February 3, 2036 . This provides a seven-year exercise window after vesting, aligning with long-term executive incentive structures.

Q: How many derivative securities does Avrohom J. Kess own after this TRV option grant?

Following the grant, Kess beneficially owns 14,691 derivative securities , all in the form of these stock options. The filing shows this entire amount as directly owned, with no indirect ownership structure indicated.

Q: What is Avrohom J. Kess’s role at The Travelers Companies, Inc.?

Avrohom J. Kess is reported as an officer of Travelers , serving as Vice Chairman and Chief Legal Officer. The stock option grant reflects compensation tied to his senior leadership position at the company.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

The Travelers Companies, Inc. reported that executive Avrohom J. Kess, Vice Chairman and Chief Legal Officer, received a grant of stock options. On February 3, 2026, he was awarded options to buy 14,691 shares of Travelers common stock at an exercise price of $288.23 per share.

The options become exercisable on February 3, 2029 and expire on February 3, 2036. After this grant, Kess beneficially owns 14,691 derivative securities directly in the form of these stock options.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kess Avrohom J.

Role Vice Chmn & Chief Legal Off

Type	Security	Shares	Price	Value
Grant/Award	Stock Options (Right to Buy)	14,691	$0.00	$0.00

Holdings After Transaction: Stock Options (Right to Buy) — 14,691 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/05/2026 - 04:14 PM

FAQ

What insider transaction did TRV report for Avrohom J. Kess?

Travelers disclosed a stock option grant to Avrohom J. Kess. On February 3, 2026, he received options to buy 14,691 shares of common stock, reflecting routine executive compensation rather than an open-market purchase or sale.

How many Travelers (TRV) stock options were granted to Avrohom J. Kess?

Avrohom J. Kess was granted 14,691 stock options. Each option represents the right to buy one share of Travelers common stock, giving him potential future ownership of up to 14,691 shares if exercised.

What is the exercise price of the new TRV stock options granted?

The newly granted stock options have an exercise price of $288.23 per share. This means Kess can buy Travelers common stock at $288.23 if he exercises the options once they become exercisable.

When do Avrohom J. Kess’s Travelers stock options vest and expire?

The options become exercisable on February 3, 2029 and expire on February 3, 2036. This provides a seven-year exercise window after vesting, aligning with long-term executive incentive structures.

How many derivative securities does Avrohom J. Kess own after this TRV option grant?

Following the grant, Kess beneficially owns 14,691 derivative securities, all in the form of these stock options. The filing shows this entire amount as directly owned, with no indirect ownership structure indicated.

What is Avrohom J. Kess’s role at The Travelers Companies, Inc.?

Avrohom J. Kess is reported as an officer of Travelers, serving as Vice Chairman and Chief Legal Officer. The stock option grant reflects compensation tied to his senior leadership position at the company.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kess Avrohom J.

(Last)

(First)

(Middle)

THE TRAVELERS COMPANIES, INC.

385 WASHINGTON STREET

(Street)

ST. PAUL

55102

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
TRAVELERS COMPANIES, INC. [ TRV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Vice Chmn & Chief Legal Off

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Options (Right to Buy)	$288.23	02/03/2026		A		14,691		02/03/2029	02/03/2036	Common Stock	14,691	$0	14,691	D

Explanation of Responses:

	/s/ Wendy C. Skjerven, by power of attorney	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR